NCT02684526View on ClinicalTrials.gov

Is Eovist Suitable for Arterial-Phase MR Imaging of Liver

NACompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

August 31, 2016

Study Completion Date

October 31, 2016

Conditions
Liver Disease
Interventions
PROCEDURE

Eovist Contrast

Subjects will undergo an MRI (magnetic resonance imaging) scan using the Eovist contrast agent. This MRI scan takes approximately 45minutes to 1 hour to complete.

PROCEDURE

Non Eovist Contrast

Subjects will undergo an MRI (magnetic resonance imaging) scan using a contrast agent other than Eovist. This MRI scan takes approximately 45minutes to 1 hour to complete.

Trial Locations (1)

48109

University of Michigan Hospital, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT02684526 - Is Eovist Suitable for Arterial-Phase MR Imaging of Liver | Biotech Hunter | Biotech Hunter